Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving Average - Here's Why

Core Laboratories Inc. (NYSE:CLB - Get Free Report)'s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.10 and traded as high as $18.78. Core Laboratories shares last traded at $18.3150, with a volume of 312,640 shares traded.Get Core Laboratories alerts:Wall Street Analyst Weigh InMarketBeat ‘Stock of the Week’: Halliburton Is One Slick Oil PlaySeparately, Weiss Ratings restated a "hold (c)" rating on shares of Core Laboratories in a research note on Monday, December 29th. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $12.50.Check Out Our Latest Research Report on Core LaboratoriesCore Laboratories Stock Down 0.6%The company's 50 day simple moving average is $18.23 and its 200-day simple moving average is $15.10. The company has a current ratio of 2.07, a quick ratio of 1.57 and a debt-to-equity ratio of 0.39. The firm has a market cap of $852.75 million, a P/E ratio of 27.34, a PEG ratio of 16.07 and a beta of 1.09. Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.01. The firm had revenue of $138.26 million during the quarter, compared to analysts' expectations of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The firm's quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. Research analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year. Core Laboratories Announces DividendThe company also recently disclosed a quarterly dividend, which will be paid on Monday, March 9th. Investors of record on Monday, February 16th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Core Laboratories's payout ratio is presently 5.97%. Institutional Inflows and OutflowsSeveral institutional investors and hedge funds have recently bought and sold shares of the company. Aster Capital Management DIFC Ltd purchased a new stake in shares of Core Laboratories during the 4th quarter valued at about $34,000. Quarry LP grew its position in Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company's stock valued at $36,000 after buying an additional 1,599 shares during the period. CWM LLC increased its holdings in Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company's stock valued at $40,000 after buying an additional 668 shares during the last quarter. Hantz Financial Services Inc. increased its holdings in Core Laboratories by 124.7% during the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company's stock valued at $51,000 after buying an additional 1,763 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in Core Laboratories by 73.3% in the fourth quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company's stock worth $83,000 after acquiring an additional 2,181 shares during the period. 97.81% of the stock is owned by hedge funds and other institutional investors. Core Laboratories Company Profile (Get Free Report)Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets. The company's portfolio spans two primary service lines: reservoir description and production enhancement.Featured StoriesFive stocks we like better than Core LaboratoriesElon Musk already made me a “wealthy man”Elon’s Secret AI Partner?Elon Musk: This Could Turn $100 into $100,000Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why~$1.5T SpaceX IPO: Pre-IPO OpportunityThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Core Laboratories Right Now?Before you consider Core Laboratories, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.While Core Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here